|
Delayed
Bombay S.E.
01:02:58 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 2,958.90 INR | +1.03% |
|
+0.42% | +19.75% |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 08-03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1% | 1% | 42.99x | 18.91x | - | - | - | 5.3B | |
| 0.6% | 0.67% | 32.72x | 20.76x | 11.9x | 24.26x | 25.57x | 1,024B | |
| 1.95% | 2.04% | 30.62x | - | - | - | - | 663B | |
| 2.67% | 2.81% | 32.73x | -359.23x | 7.6x | 15.8x | 16.42x | 453B | |
| 2.83% | 2.9% | 19.22x | 7.03x | 4.69x | 11.6x | 12.86x | 349B | |
| 2.82% | 2.94% | 22.02x | 6.23x | 5.68x | 14.1x | 15.03x | 295B | |
| 2.05% | 2.18% | 20.97x | 4.69x | 4.3x | 12.3x | 12.93x | 253B | |
| 2.31% | 2.44% | 27.66x | 20.89x | 7.14x | 13.16x | 16.38x | 236B | |
| 3.78% | 3.76% | 13.33x | 5.65x | 4.82x | 10.06x | 11.7x | 206B | |
| 2.18% | 2.25% | -46.14x | 10.28x | 6.65x | 25.95x | 63.22x | 187B | |
| 6.05% | 6.1% | 17.83x | 1.85x | 3.37x | 8.6x | 9.81x | 162B | |
| -.--% | -.--% | 32.2x | 7.23x | 9.69x | 29.39x | 27.19x | 138B | |
| 3.78% | 3.85% | 11.9x | 5.61x | 3.31x | 8.6x | 9.32x | 136B | |
| 5.62% | 5.94% | 12.05x | 1.23x | 2.14x | 6.93x | 7.73x | 105B | |
| 3.79% | 4.08% | 13.92x | 4.49x | 2.75x | 8.16x | 9.09x | 99.72B | |
| 2.07% | 2.36% | 21.34x | 4.81x | 7.12x | 13.52x | 14.19x | 70.01B | |
| 3.54% | 3.61% | 45.74x | 1.24x | 2.79x | 9.87x | 27.93x | 59.8B | |
| 0.33% | 1.15% | 22.08x | 1.7x | 1.7x | 8.03x | 13.79x | 55.64B | |
| 0.53% | 0.6% | 33.22x | 4.48x | 7.79x | 26.39x | 27.6x | 45.39B | |
| -.--% | -.--% | 48.78x | 4.91x | 3.27x | 12.07x | 13.65x | 42.37B | |
| Average | 2.39% | 2.53% | 22.76x | -11.96x | 5.37x | 14.38x | 18.58x | 229.4B | |
| Weighted average by Cap. | 2.19% | 2.3% | 23.69x | -31.69x | 7.16x | 16.65x | 19.79x |
Select your edition
All financial news and data tailored to specific country editions
